Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Wilms Tumor | 54 | 2024 | 375 | 6.860 |
Why?
|
Kidney Neoplasms | 52 | 2024 | 4312 | 2.750 |
Why?
|
Nephrectomy | 32 | 2024 | 1016 | 1.850 |
Why?
|
Neuroblastoma | 23 | 2024 | 1252 | 1.460 |
Why?
|
Proctocolectomy, Restorative | 8 | 2013 | 190 | 1.240 |
Why?
|
Abdominal Neoplasms | 9 | 2010 | 286 | 0.820 |
Why?
|
Funnel Chest | 11 | 2013 | 74 | 0.820 |
Why?
|
Mediastinal Neoplasms | 7 | 2008 | 402 | 0.800 |
Why?
|
Adenomatous Polyposis Coli | 4 | 2010 | 218 | 0.780 |
Why?
|
Adrenal Gland Neoplasms | 8 | 2012 | 733 | 0.740 |
Why?
|
Anatomists | 1 | 2020 | 10 | 0.730 |
Why?
|
Colitis, Ulcerative | 11 | 2017 | 1919 | 0.720 |
Why?
|
Watchful Waiting | 2 | 2017 | 510 | 0.720 |
Why?
|
Hepatoblastoma | 3 | 2015 | 88 | 0.640 |
Why?
|
Child | 127 | 2024 | 79799 | 0.640 |
Why?
|
Anatomy | 1 | 2020 | 126 | 0.620 |
Why?
|
Neoplasm Staging | 38 | 2023 | 11152 | 0.590 |
Why?
|
Child, Preschool | 99 | 2024 | 42056 | 0.590 |
Why?
|
Colonic Pouches | 4 | 2013 | 122 | 0.560 |
Why?
|
Neoplasm Recurrence, Local | 16 | 2024 | 9278 | 0.540 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 31 | 2022 | 11713 | 0.520 |
Why?
|
Neuroectodermal Tumors, Primitive | 4 | 2003 | 136 | 0.520 |
Why?
|
Dactinomycin | 16 | 2022 | 304 | 0.520 |
Why?
|
Infant | 86 | 2024 | 36053 | 0.500 |
Why?
|
Hepatocyte Growth Factor | 1 | 2015 | 267 | 0.450 |
Why?
|
Hospitals, Pediatric | 5 | 2018 | 1854 | 0.440 |
Why?
|
Vincristine | 17 | 2022 | 1038 | 0.440 |
Why?
|
Liver Neoplasms | 9 | 2017 | 4319 | 0.440 |
Why?
|
WAGR Syndrome | 2 | 2024 | 4 | 0.430 |
Why?
|
Combined Modality Therapy | 32 | 2020 | 8552 | 0.420 |
Why?
|
Thoracic Neoplasms | 5 | 2010 | 266 | 0.410 |
Why?
|
Thyroid Nodule | 6 | 2022 | 760 | 0.400 |
Why?
|
Bone Neoplasms | 9 | 2014 | 2531 | 0.400 |
Why?
|
Education, Medical, Undergraduate | 1 | 2020 | 1066 | 0.370 |
Why?
|
Preoperative Care | 5 | 2011 | 2255 | 0.370 |
Why?
|
Thorax | 4 | 2000 | 553 | 0.370 |
Why?
|
Neoplasms, Multiple Primary | 4 | 2011 | 586 | 0.350 |
Why?
|
Disease-Free Survival | 20 | 2017 | 6831 | 0.350 |
Why?
|
Adolescent | 93 | 2024 | 87809 | 0.350 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2017 | 2299 | 0.330 |
Why?
|
Respiratory System Abnormalities | 1 | 2010 | 67 | 0.330 |
Why?
|
Cardiovascular Abnormalities | 1 | 2010 | 143 | 0.330 |
Why?
|
Humans | 212 | 2024 | 760613 | 0.320 |
Why?
|
Catecholamines | 2 | 2009 | 385 | 0.310 |
Why?
|
Ribs | 4 | 2008 | 252 | 0.290 |
Why?
|
Multicenter Studies as Topic | 1 | 2013 | 1722 | 0.290 |
Why?
|
Students, Medical | 1 | 2020 | 1927 | 0.280 |
Why?
|
Survival Rate | 19 | 2024 | 12810 | 0.280 |
Why?
|
Biopsy, Needle | 4 | 2011 | 1630 | 0.260 |
Why?
|
Splenic Diseases | 2 | 1997 | 90 | 0.260 |
Why?
|
Male | 132 | 2024 | 359718 | 0.260 |
Why?
|
Physician's Role | 1 | 2013 | 918 | 0.260 |
Why?
|
Splenectomy | 3 | 2019 | 391 | 0.260 |
Why?
|
Hodgkin Disease | 6 | 2008 | 1380 | 0.260 |
Why?
|
Neoplasm Seeding | 3 | 2013 | 84 | 0.250 |
Why?
|
Twins, Conjoined | 2 | 2003 | 41 | 0.250 |
Why?
|
Thoracic Surgical Procedures | 3 | 2010 | 348 | 0.250 |
Why?
|
Radiography, Thoracic | 3 | 2011 | 1296 | 0.250 |
Why?
|
Lymph Node Excision | 3 | 2023 | 1303 | 0.250 |
Why?
|
Chemotherapy, Adjuvant | 13 | 2017 | 3530 | 0.240 |
Why?
|
Neoplasms, Muscle Tissue | 1 | 2005 | 67 | 0.240 |
Why?
|
Female | 119 | 2024 | 391246 | 0.240 |
Why?
|
Esophagus | 2 | 2003 | 1023 | 0.240 |
Why?
|
Tomography, X-Ray Computed | 19 | 2014 | 20509 | 0.240 |
Why?
|
Follow-Up Studies | 31 | 2024 | 39262 | 0.240 |
Why?
|
Doxorubicin | 16 | 2017 | 2208 | 0.230 |
Why?
|
Thyroid Neoplasms | 6 | 2022 | 2332 | 0.230 |
Why?
|
Crohn Disease | 4 | 2017 | 2275 | 0.220 |
Why?
|
Treatment Outcome | 37 | 2020 | 64981 | 0.220 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2005 | 748 | 0.220 |
Why?
|
Airway Obstruction | 1 | 2008 | 662 | 0.220 |
Why?
|
Spleen | 4 | 1999 | 2298 | 0.220 |
Why?
|
Loss of Heterozygosity | 5 | 2019 | 659 | 0.220 |
Why?
|
Adrenalectomy | 3 | 2013 | 348 | 0.220 |
Why?
|
Retrospective Studies | 48 | 2024 | 80345 | 0.220 |
Why?
|
Neoadjuvant Therapy | 5 | 2017 | 2821 | 0.210 |
Why?
|
Lung Neoplasms | 6 | 2015 | 13262 | 0.210 |
Why?
|
Cyclooxygenase 2 | 1 | 2005 | 599 | 0.210 |
Why?
|
Kidney | 9 | 2022 | 7064 | 0.210 |
Why?
|
Radiotherapy, Adjuvant | 6 | 2017 | 1791 | 0.200 |
Why?
|
Hepatectomy | 4 | 2010 | 559 | 0.200 |
Why?
|
General Surgery | 2 | 2013 | 1678 | 0.200 |
Why?
|
Gastrointestinal Agents | 2 | 2017 | 509 | 0.200 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2022 | 101 | 0.200 |
Why?
|
Anaplasia | 4 | 2024 | 16 | 0.200 |
Why?
|
Wounds, Nonpenetrating | 2 | 1999 | 793 | 0.200 |
Why?
|
Infant, Newborn | 27 | 2017 | 26179 | 0.200 |
Why?
|
Chromosomes, Human, Pair 1 | 4 | 2019 | 635 | 0.200 |
Why?
|
Liver Function Tests | 2 | 2009 | 524 | 0.190 |
Why?
|
Pulmonary Blastoma | 1 | 2001 | 41 | 0.190 |
Why?
|
Radiography | 11 | 2013 | 6965 | 0.190 |
Why?
|
Hashimoto Disease | 1 | 2022 | 105 | 0.190 |
Why?
|
Respiratory Function Tests | 7 | 2013 | 1683 | 0.190 |
Why?
|
Medical Oncology | 1 | 2013 | 2313 | 0.180 |
Why?
|
Renal Artery Obstruction | 1 | 2001 | 224 | 0.170 |
Why?
|
Labetalol | 2 | 2010 | 29 | 0.170 |
Why?
|
Splenic Vein | 1 | 1999 | 30 | 0.170 |
Why?
|
Specialties, Surgical | 2 | 2023 | 388 | 0.170 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 3 | 2006 | 265 | 0.170 |
Why?
|
Lymphoma | 1 | 2008 | 1899 | 0.160 |
Why?
|
Ventricular Dysfunction | 1 | 2000 | 145 | 0.160 |
Why?
|
Spherocytosis, Hereditary | 1 | 2019 | 84 | 0.160 |
Why?
|
Esophagectomy | 1 | 2003 | 466 | 0.160 |
Why?
|
Aortic Coarctation | 1 | 2001 | 282 | 0.160 |
Why?
|
Splenic Artery | 1 | 1999 | 57 | 0.160 |
Why?
|
Prognosis | 20 | 2024 | 29661 | 0.160 |
Why?
|
Aorta, Abdominal | 2 | 2001 | 622 | 0.160 |
Why?
|
Sacrum | 2 | 1997 | 277 | 0.160 |
Why?
|
Postoperative Complications | 14 | 2017 | 15679 | 0.160 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2014 | 10343 | 0.150 |
Why?
|
Vena Cava, Inferior | 1 | 2001 | 458 | 0.150 |
Why?
|
Esophageal Cyst | 1 | 1997 | 13 | 0.150 |
Why?
|
Bronchogenic Cyst | 1 | 1997 | 28 | 0.150 |
Why?
|
Radiography, Interventional | 1 | 2005 | 1112 | 0.150 |
Why?
|
Biopsy | 10 | 2013 | 6771 | 0.150 |
Why?
|
Pediatrics | 1 | 2013 | 3586 | 0.150 |
Why?
|
Pleural Effusion, Malignant | 1 | 1998 | 103 | 0.150 |
Why?
|
Respiratory Insufficiency | 2 | 2011 | 1231 | 0.150 |
Why?
|
Cutaneous Fistula | 1 | 1997 | 79 | 0.140 |
Why?
|
Angioplasty, Balloon | 1 | 2001 | 597 | 0.140 |
Why?
|
Cyclophosphamide | 9 | 2010 | 2222 | 0.140 |
Why?
|
Bacterial Vaccines | 3 | 1996 | 401 | 0.140 |
Why?
|
Fanconi Syndrome | 1 | 2017 | 34 | 0.140 |
Why?
|
Trachea | 3 | 2010 | 1082 | 0.140 |
Why?
|
Gene Fusion | 1 | 2019 | 354 | 0.140 |
Why?
|
Hamartoma Syndrome, Multiple | 2 | 2010 | 114 | 0.140 |
Why?
|
Imaging, Three-Dimensional | 1 | 2010 | 4046 | 0.140 |
Why?
|
Haemophilus Vaccines | 2 | 1995 | 71 | 0.140 |
Why?
|
Anal Canal | 3 | 2013 | 372 | 0.130 |
Why?
|
Pleural Neoplasms | 1 | 2001 | 609 | 0.130 |
Why?
|
Vascular Surgical Procedures | 2 | 2001 | 1469 | 0.130 |
Why?
|
Blood Vessel Prosthesis | 1 | 2001 | 945 | 0.130 |
Why?
|
Sex Distribution | 3 | 2017 | 2294 | 0.130 |
Why?
|
Prospective Studies | 22 | 2022 | 54306 | 0.130 |
Why?
|
Abdominal Injuries | 1 | 1999 | 359 | 0.130 |
Why?
|
Arteriovenous Fistula | 1 | 1999 | 314 | 0.130 |
Why?
|
Intestinal Obstruction | 4 | 2017 | 434 | 0.130 |
Why?
|
Spina Bifida Occulta | 1 | 1995 | 31 | 0.130 |
Why?
|
Survival Analysis | 11 | 2017 | 10185 | 0.130 |
Why?
|
Abscess | 2 | 1997 | 605 | 0.130 |
Why?
|
Laboratories | 1 | 2019 | 462 | 0.130 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2019 | 346 | 0.130 |
Why?
|
Perioperative Care | 4 | 2009 | 1037 | 0.120 |
Why?
|
Parenteral Nutrition, Total | 3 | 1990 | 303 | 0.120 |
Why?
|
Neoplasms | 6 | 2013 | 22075 | 0.120 |
Why?
|
Anus, Imperforate | 1 | 1995 | 64 | 0.120 |
Why?
|
Antibodies, Bacterial | 2 | 1992 | 1468 | 0.120 |
Why?
|
Epidermal Cyst | 1 | 1995 | 64 | 0.120 |
Why?
|
Reoperation | 7 | 2006 | 4289 | 0.120 |
Why?
|
Choledochal Cyst | 1 | 1995 | 25 | 0.120 |
Why?
|
Neoplasm Invasiveness | 5 | 2017 | 3618 | 0.120 |
Why?
|
Nutrition Disorders | 2 | 1994 | 205 | 0.120 |
Why?
|
Precancerous Conditions | 1 | 2022 | 977 | 0.120 |
Why?
|
Whole-Body Irradiation | 2 | 2006 | 433 | 0.120 |
Why?
|
Haemophilus influenzae | 2 | 1992 | 180 | 0.120 |
Why?
|
Common Bile Duct | 1 | 1995 | 106 | 0.120 |
Why?
|
Adrenergic alpha-Antagonists | 3 | 2010 | 174 | 0.120 |
Why?
|
Liver Regeneration | 1 | 1996 | 213 | 0.120 |
Why?
|
Pancreatin | 1 | 1994 | 9 | 0.120 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2001 | 938 | 0.120 |
Why?
|
Quality Assurance, Health Care | 1 | 2005 | 2176 | 0.120 |
Why?
|
Genes, Wilms Tumor | 2 | 2011 | 92 | 0.120 |
Why?
|
Age Factors | 8 | 2014 | 18413 | 0.120 |
Why?
|
Soft Tissue Neoplasms | 4 | 2009 | 1152 | 0.110 |
Why?
|
Pheochromocytoma | 2 | 2007 | 328 | 0.110 |
Why?
|
Ileum | 1 | 2016 | 555 | 0.110 |
Why?
|
Adenocarcinoma, Follicular | 2 | 2010 | 325 | 0.110 |
Why?
|
Colon | 5 | 2003 | 1788 | 0.110 |
Why?
|
Remission Induction | 4 | 2008 | 2392 | 0.110 |
Why?
|
Anesthesia, General | 2 | 1999 | 1166 | 0.110 |
Why?
|
Rectum | 2 | 2000 | 895 | 0.110 |
Why?
|
Electrolytes | 1 | 1994 | 274 | 0.110 |
Why?
|
Plasmapheresis | 1 | 2014 | 206 | 0.110 |
Why?
|
Lung Transplantation | 4 | 1999 | 1305 | 0.110 |
Why?
|
Pentetic Acid | 1 | 1993 | 209 | 0.110 |
Why?
|
Water-Electrolyte Balance | 1 | 1994 | 325 | 0.110 |
Why?
|
Hemoglobin SC Disease | 1 | 1993 | 23 | 0.110 |
Why?
|
Rhabdomyosarcoma | 6 | 2004 | 359 | 0.110 |
Why?
|
Cholelithiasis | 2 | 1993 | 408 | 0.110 |
Why?
|
Surgical Flaps | 2 | 2000 | 1669 | 0.110 |
Why?
|
Age Distribution | 2 | 2017 | 2893 | 0.110 |
Why?
|
Meglumine | 1 | 1993 | 145 | 0.110 |
Why?
|
Laparotomy | 2 | 1995 | 465 | 0.110 |
Why?
|
Laparoscopy | 3 | 2016 | 2147 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 1998 | 1378 | 0.110 |
Why?
|
Jejunum | 1 | 1995 | 471 | 0.100 |
Why?
|
Polysaccharides, Bacterial | 3 | 1996 | 574 | 0.100 |
Why?
|
Duodenum | 2 | 1995 | 486 | 0.100 |
Why?
|
Lipoma | 2 | 2010 | 292 | 0.100 |
Why?
|
Cell Separation | 2 | 1996 | 1720 | 0.100 |
Why?
|
Premedication | 2 | 2002 | 253 | 0.100 |
Why?
|
Head and Neck Neoplasms | 2 | 2005 | 2882 | 0.100 |
Why?
|
Blood Component Transfusion | 1 | 1993 | 141 | 0.100 |
Why?
|
Tetanus Toxoid | 1 | 1992 | 193 | 0.100 |
Why?
|
Transplantation, Autologous | 4 | 2006 | 2120 | 0.100 |
Why?
|
Catheter Ablation | 1 | 2005 | 2758 | 0.100 |
Why?
|
Cysts | 2 | 1998 | 683 | 0.100 |
Why?
|
Adult | 47 | 2019 | 220007 | 0.100 |
Why?
|
Feedback | 1 | 2015 | 791 | 0.100 |
Why?
|
Lymphatic Metastasis | 3 | 2017 | 2943 | 0.100 |
Why?
|
Purpura, Thrombocytopenic | 1 | 1991 | 41 | 0.100 |
Why?
|
Cholecystectomy | 2 | 1993 | 406 | 0.100 |
Why?
|
Myasthenia Gravis | 1 | 2014 | 213 | 0.100 |
Why?
|
Boston | 8 | 2012 | 9278 | 0.100 |
Why?
|
Forced Expiratory Flow Rates | 1 | 2011 | 75 | 0.100 |
Why?
|
Antineoplastic Agents | 10 | 2019 | 13627 | 0.090 |
Why?
|
Immunohistochemistry | 6 | 2011 | 11070 | 0.090 |
Why?
|
Wound Healing | 4 | 1985 | 2788 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 5 | 2013 | 6544 | 0.090 |
Why?
|
Surgery Department, Hospital | 1 | 1992 | 177 | 0.090 |
Why?
|
Neoplasms, Second Primary | 3 | 2008 | 1060 | 0.090 |
Why?
|
Sarcoma | 5 | 1997 | 1786 | 0.090 |
Why?
|
Radiotherapy | 5 | 2013 | 1504 | 0.090 |
Why?
|
Methods | 4 | 1995 | 1074 | 0.090 |
Why?
|
Dopamine | 2 | 2010 | 1595 | 0.090 |
Why?
|
Chromosomes, Human, Pair 11 | 2 | 2010 | 410 | 0.090 |
Why?
|
Pokeweed Mitogens | 1 | 1990 | 38 | 0.090 |
Why?
|
Sternum | 2 | 1988 | 175 | 0.090 |
Why?
|
beta-Thalassemia | 1 | 1993 | 235 | 0.090 |
Why?
|
Pancreaticoduodenectomy | 1 | 1994 | 508 | 0.090 |
Why?
|
Etoposide | 5 | 2010 | 630 | 0.090 |
Why?
|
Respiratory Tract Neoplasms | 1 | 2010 | 57 | 0.090 |
Why?
|
Medical Audit | 2 | 2005 | 453 | 0.090 |
Why?
|
Orthopedic Procedures | 3 | 2013 | 1263 | 0.090 |
Why?
|
Lung Diseases, Fungal | 2 | 1992 | 126 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2024 | 2290 | 0.090 |
Why?
|
Poland Syndrome | 1 | 1989 | 14 | 0.090 |
Why?
|
Heart Defects, Congenital | 2 | 2002 | 4673 | 0.090 |
Why?
|
Risk | 5 | 2012 | 9632 | 0.090 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2011 | 160 | 0.080 |
Why?
|
Organometallic Compounds | 1 | 1993 | 662 | 0.080 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2014 | 664 | 0.080 |
Why?
|
Burkitt Lymphoma | 1 | 1992 | 333 | 0.080 |
Why?
|
Embolization, Therapeutic | 1 | 1999 | 1412 | 0.080 |
Why?
|
Phenoxybenzamine | 1 | 2009 | 53 | 0.080 |
Why?
|
Nurse Practitioners | 1 | 1992 | 268 | 0.080 |
Why?
|
Li-Fraumeni Syndrome | 1 | 2010 | 117 | 0.080 |
Why?
|
Kidney Failure, Chronic | 2 | 2012 | 2470 | 0.080 |
Why?
|
Neurofibroma | 1 | 1989 | 94 | 0.080 |
Why?
|
Treatment Failure | 3 | 2006 | 2647 | 0.080 |
Why?
|
Syndactyly | 1 | 1989 | 72 | 0.080 |
Why?
|
Adenoma | 3 | 2011 | 2148 | 0.080 |
Why?
|
Focal Nodular Hyperplasia | 1 | 2008 | 29 | 0.080 |
Why?
|
Parenteral Nutrition | 2 | 1984 | 656 | 0.080 |
Why?
|
Digestive System Surgical Procedures | 1 | 2014 | 575 | 0.080 |
Why?
|
Ultrasonography, Prenatal | 4 | 2002 | 1745 | 0.080 |
Why?
|
Anastomosis, Surgical | 3 | 2013 | 983 | 0.080 |
Why?
|
Polyethylene Glycols | 1 | 1994 | 1189 | 0.080 |
Why?
|
Staphylococcal Infections | 1 | 1997 | 1407 | 0.080 |
Why?
|
Bone Marrow Examination | 1 | 2008 | 155 | 0.080 |
Why?
|
Hypertension | 3 | 2009 | 8595 | 0.080 |
Why?
|
Cohort Studies | 9 | 2017 | 41337 | 0.080 |
Why?
|
Keratins | 1 | 2010 | 497 | 0.080 |
Why?
|
Paracentesis | 1 | 2008 | 98 | 0.080 |
Why?
|
Thigh | 1 | 1989 | 240 | 0.080 |
Why?
|
Animals, Newborn | 2 | 1999 | 2671 | 0.080 |
Why?
|
Vital Capacity | 1 | 2011 | 965 | 0.080 |
Why?
|
Membrane Proteins | 1 | 2005 | 7850 | 0.080 |
Why?
|
Defecation | 1 | 2009 | 190 | 0.080 |
Why?
|
Risk Assessment | 7 | 2017 | 24102 | 0.080 |
Why?
|
Body Image | 2 | 2013 | 635 | 0.080 |
Why?
|
Tumor Burden | 1 | 2014 | 1895 | 0.080 |
Why?
|
Antihypertensive Agents | 2 | 2010 | 2061 | 0.070 |
Why?
|
Testis | 2 | 1981 | 794 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 368 | 0.070 |
Why?
|
Lung Diseases | 3 | 2006 | 1915 | 0.070 |
Why?
|
Ureteral Neoplasms | 1 | 2008 | 110 | 0.070 |
Why?
|
Lung | 5 | 1999 | 9994 | 0.070 |
Why?
|
Quality of Life | 3 | 2010 | 13308 | 0.070 |
Why?
|
Esophagitis | 1 | 1988 | 163 | 0.070 |
Why?
|
Liposarcoma | 1 | 2010 | 283 | 0.070 |
Why?
|
Fibrosarcoma | 2 | 2002 | 308 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2010 | 1259 | 0.070 |
Why?
|
Ovary | 2 | 1981 | 958 | 0.070 |
Why?
|
Adenoma, Pleomorphic | 1 | 2007 | 75 | 0.070 |
Why?
|
Time Factors | 13 | 2017 | 40139 | 0.070 |
Why?
|
Case Management | 1 | 2008 | 272 | 0.070 |
Why?
|
Curriculum | 1 | 2020 | 3718 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 4 | 2011 | 1869 | 0.070 |
Why?
|
Radiotherapy Dosage | 4 | 2024 | 2897 | 0.070 |
Why?
|
History, 21st Century | 1 | 2013 | 1575 | 0.070 |
Why?
|
Antibiotics, Antineoplastic | 2 | 2007 | 675 | 0.070 |
Why?
|
Bone Marrow Neoplasms | 1 | 2007 | 101 | 0.070 |
Why?
|
History, 20th Century | 2 | 2013 | 2773 | 0.070 |
Why?
|
Common Bile Duct Diseases | 1 | 1985 | 36 | 0.070 |
Why?
|
Bronchi | 1 | 2010 | 848 | 0.070 |
Why?
|
Parotid Neoplasms | 1 | 2007 | 157 | 0.070 |
Why?
|
Esophageal Atresia | 1 | 1988 | 217 | 0.060 |
Why?
|
Preanesthetic Medication | 1 | 2005 | 48 | 0.060 |
Why?
|
Mitral Valve Prolapse | 1 | 1987 | 215 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2000 | 4924 | 0.060 |
Why?
|
Osteosarcoma | 4 | 2008 | 897 | 0.060 |
Why?
|
Muscles | 2 | 1991 | 1581 | 0.060 |
Why?
|
Incidence | 5 | 2017 | 21391 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2018 | 5508 | 0.060 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2008 | 1539 | 0.060 |
Why?
|
Thyroidectomy | 1 | 2011 | 902 | 0.060 |
Why?
|
Risk Factors | 14 | 2024 | 74333 | 0.060 |
Why?
|
Double Outlet Right Ventricle | 1 | 2005 | 60 | 0.060 |
Why?
|
Intestinal Fistula | 2 | 2014 | 143 | 0.060 |
Why?
|
Abdominal Cavity | 1 | 2005 | 34 | 0.060 |
Why?
|
Immunologic Factors | 1 | 2014 | 1588 | 0.060 |
Why?
|
Biological Products | 1 | 2014 | 916 | 0.060 |
Why?
|
Bone Diseases | 1 | 2008 | 418 | 0.060 |
Why?
|
beta Catenin | 1 | 2010 | 1043 | 0.060 |
Why?
|
Pancreatitis | 3 | 2007 | 1100 | 0.060 |
Why?
|
Enterocolitis | 1 | 1986 | 106 | 0.060 |
Why?
|
Barrett Esophagus | 1 | 1988 | 490 | 0.060 |
Why?
|
Congenital Abnormalities | 2 | 2002 | 704 | 0.060 |
Why?
|
Activin Receptors, Type II | 1 | 2005 | 124 | 0.060 |
Why?
|
Recurrence | 6 | 2009 | 8483 | 0.060 |
Why?
|
Peritoneovenous Shunt | 1 | 1984 | 9 | 0.060 |
Why?
|
Diverticulum | 1 | 1985 | 137 | 0.060 |
Why?
|
Antigens, Bacterial | 1 | 1990 | 1155 | 0.060 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 1989 | 494 | 0.060 |
Why?
|
Hemodynamics | 2 | 2000 | 4173 | 0.060 |
Why?
|
Megacolon | 1 | 1983 | 11 | 0.060 |
Why?
|
Social Behavior | 1 | 2010 | 1131 | 0.060 |
Why?
|
Intraoperative Period | 1 | 2005 | 516 | 0.060 |
Why?
|
Syndrome | 4 | 2001 | 3280 | 0.060 |
Why?
|
Forecasting | 1 | 2013 | 2931 | 0.060 |
Why?
|
Hematopoietic Stem Cells | 1 | 1996 | 3390 | 0.050 |
Why?
|
Neoplasm Metastasis | 3 | 2020 | 4902 | 0.050 |
Why?
|
Pancreas | 3 | 1998 | 1677 | 0.050 |
Why?
|
Antineoplastic Agents, Phytogenic | 1 | 2007 | 626 | 0.050 |
Why?
|
Inguinal Canal | 1 | 2003 | 71 | 0.050 |
Why?
|
Agranulocytosis | 1 | 1983 | 99 | 0.050 |
Why?
|
Anesthesia, Caudal | 1 | 2003 | 33 | 0.050 |
Why?
|
Iliac Artery | 1 | 1984 | 344 | 0.050 |
Why?
|
Norepinephrine | 1 | 2005 | 900 | 0.050 |
Why?
|
Calcitonin | 2 | 2019 | 330 | 0.050 |
Why?
|
Esophageal Achalasia | 1 | 2003 | 94 | 0.050 |
Why?
|
Sex Factors | 3 | 2011 | 10546 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 7 | 2007 | 36286 | 0.050 |
Why?
|
Carboplatin | 3 | 2010 | 789 | 0.050 |
Why?
|
Epinephrine | 1 | 2005 | 791 | 0.050 |
Why?
|
Kidney Diseases, Cystic | 1 | 2003 | 183 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2000 | 5659 | 0.050 |
Why?
|
Esophageal Stenosis | 1 | 2003 | 192 | 0.050 |
Why?
|
Tracheoesophageal Fistula | 1 | 2003 | 131 | 0.050 |
Why?
|
Hernia, Inguinal | 1 | 1984 | 220 | 0.050 |
Why?
|
Sarcoma, Clear Cell | 3 | 2006 | 72 | 0.050 |
Why?
|
Attitude of Health Personnel | 1 | 2015 | 3865 | 0.050 |
Why?
|
Chromosomes, Human, Pair 16 | 2 | 2017 | 342 | 0.050 |
Why?
|
Fontan Procedure | 1 | 2007 | 791 | 0.050 |
Why?
|
Diagnosis, Differential | 8 | 2010 | 12968 | 0.050 |
Why?
|
Cell Nucleus | 1 | 2010 | 2907 | 0.050 |
Why?
|
Aortography | 2 | 2001 | 419 | 0.050 |
Why?
|
Testicular Neoplasms | 3 | 1999 | 801 | 0.050 |
Why?
|
Radionuclide Ventriculography | 1 | 2000 | 40 | 0.050 |
Why?
|
Growth Disorders | 2 | 1997 | 653 | 0.050 |
Why?
|
Fetofetal Transfusion | 1 | 2002 | 112 | 0.050 |
Why?
|
Teratoma | 2 | 1996 | 403 | 0.040 |
Why?
|
Intestinal Mucosa | 2 | 2009 | 3022 | 0.040 |
Why?
|
Hyperplasia | 1 | 2004 | 1155 | 0.040 |
Why?
|
Cause of Death | 1 | 2011 | 3725 | 0.040 |
Why?
|
Methotrexate | 3 | 1981 | 1718 | 0.040 |
Why?
|
Health Surveys | 1 | 2010 | 4063 | 0.040 |
Why?
|
Decision Support Techniques | 1 | 2010 | 2001 | 0.040 |
Why?
|
Quality Improvement | 1 | 2015 | 3835 | 0.040 |
Why?
|
Femoral Artery | 1 | 1984 | 831 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 2 | 1986 | 3610 | 0.040 |
Why?
|
Ultrasonic Therapy | 1 | 1981 | 215 | 0.040 |
Why?
|
Interleukin-6 | 1 | 1990 | 3215 | 0.040 |
Why?
|
Ultrasonography | 6 | 2013 | 5961 | 0.040 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2011 | 2282 | 0.040 |
Why?
|
Rhabdoid Tumor | 3 | 2006 | 210 | 0.040 |
Why?
|
Clinical Competence | 1 | 2015 | 4783 | 0.040 |
Why?
|
Genes, myc | 3 | 1996 | 395 | 0.040 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2010 | 2924 | 0.040 |
Why?
|
Scleroderma, Systemic | 1 | 1983 | 344 | 0.040 |
Why?
|
Energy Intake | 2 | 1984 | 2129 | 0.040 |
Why?
|
Exercise Test | 2 | 2013 | 2128 | 0.040 |
Why?
|
Heart Function Tests | 1 | 2000 | 319 | 0.040 |
Why?
|
Nephroma, Mesoblastic | 1 | 1999 | 24 | 0.040 |
Why?
|
Patient Selection | 1 | 2011 | 4279 | 0.040 |
Why?
|
Leukopenia | 3 | 1985 | 212 | 0.040 |
Why?
|
Recovery of Function | 1 | 2009 | 2985 | 0.040 |
Why?
|
Thyrotropin | 1 | 2022 | 832 | 0.040 |
Why?
|
Young Adult | 9 | 2019 | 58748 | 0.040 |
Why?
|
Anastomosis, Roux-en-Y | 2 | 1998 | 86 | 0.040 |
Why?
|
Motor Activity | 1 | 2008 | 2688 | 0.040 |
Why?
|
Immunosuppressive Agents | 2 | 2013 | 4167 | 0.040 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2008 | 1403 | 0.040 |
Why?
|
Ifosfamide | 2 | 2009 | 232 | 0.040 |
Why?
|
Pancreatic Pseudocyst | 1 | 1998 | 110 | 0.040 |
Why?
|
Carbazoles | 1 | 2019 | 220 | 0.040 |
Why?
|
Surgical Sponges | 1 | 1997 | 39 | 0.040 |
Why?
|
Ileus | 1 | 2017 | 57 | 0.040 |
Why?
|
Rest | 1 | 2022 | 914 | 0.040 |
Why?
|
Intestine, Small | 1 | 1984 | 1207 | 0.040 |
Why?
|
Surgical Stomas | 1 | 2017 | 42 | 0.040 |
Why?
|
Aspergillosis | 2 | 1992 | 243 | 0.040 |
Why?
|
Tensile Strength | 3 | 1985 | 330 | 0.040 |
Why?
|
Streptococcus pneumoniae | 2 | 1996 | 732 | 0.040 |
Why?
|
Photogrammetry | 2 | 1988 | 77 | 0.040 |
Why?
|
Interferometry | 2 | 1988 | 100 | 0.040 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2000 | 1131 | 0.040 |
Why?
|
Vaccines, Conjugate | 2 | 1996 | 328 | 0.040 |
Why?
|
Anesthesia | 2 | 2005 | 1584 | 0.040 |
Why?
|
Necrosis | 2 | 2010 | 1612 | 0.040 |
Why?
|
Ileostomy | 1 | 2017 | 120 | 0.040 |
Why?
|
Drug Therapy | 1 | 2020 | 504 | 0.040 |
Why?
|
Testosterone | 3 | 1982 | 2470 | 0.030 |
Why?
|
Pain, Postoperative | 1 | 2007 | 1720 | 0.030 |
Why?
|
Kidney Transplantation | 1 | 2012 | 4214 | 0.030 |
Why?
|
Tacrolimus | 2 | 2013 | 733 | 0.030 |
Why?
|
Registries | 2 | 2011 | 8458 | 0.030 |
Why?
|
Severity of Illness Index | 4 | 2012 | 15840 | 0.030 |
Why?
|
Infarction | 1 | 1998 | 248 | 0.030 |
Why?
|
B-Lymphocytes | 1 | 1990 | 4742 | 0.030 |
Why?
|
Mitotic Index | 2 | 2011 | 161 | 0.030 |
Why?
|
Incidental Findings | 2 | 2013 | 698 | 0.030 |
Why?
|
Sacrococcygeal Region | 1 | 1996 | 53 | 0.030 |
Why?
|
Ploidies | 1 | 1996 | 275 | 0.030 |
Why?
|
Maximal Expiratory Flow Rate | 1 | 1995 | 42 | 0.030 |
Why?
|
Ileocecal Valve | 1 | 1995 | 21 | 0.030 |
Why?
|
Cytogenetics | 1 | 1996 | 198 | 0.030 |
Why?
|
Veins | 1 | 2000 | 765 | 0.030 |
Why?
|
Leukapheresis | 1 | 1996 | 134 | 0.030 |
Why?
|
Acute Disease | 4 | 2011 | 7268 | 0.030 |
Why?
|
Gastroesophageal Reflux | 1 | 2003 | 816 | 0.030 |
Why?
|
Ossification, Heterotopic | 1 | 1998 | 235 | 0.030 |
Why?
|
Random Allocation | 4 | 1996 | 2394 | 0.030 |
Why?
|
Myelography | 1 | 1995 | 72 | 0.030 |
Why?
|
Regression Analysis | 3 | 2001 | 6359 | 0.030 |
Why?
|
Drug Administration Schedule | 2 | 2017 | 4899 | 0.030 |
Why?
|
Disease Progression | 3 | 2011 | 13505 | 0.030 |
Why?
|
Anus Diseases | 1 | 1995 | 55 | 0.030 |
Why?
|
Diagnostic Imaging | 2 | 2022 | 3527 | 0.030 |
Why?
|
Hot Temperature | 1 | 1981 | 1435 | 0.030 |
Why?
|
Heart Atria | 1 | 2001 | 1346 | 0.030 |
Why?
|
Follicle Stimulating Hormone | 3 | 1981 | 725 | 0.030 |
Why?
|
Colectomy | 1 | 2000 | 692 | 0.030 |
Why?
|
Thrombocytopenia | 1 | 1983 | 1174 | 0.030 |
Why?
|
Heart | 1 | 1988 | 4393 | 0.030 |
Why?
|
Neovascularization, Pathologic | 1 | 2005 | 2640 | 0.030 |
Why?
|
Luteinizing Hormone | 3 | 1981 | 820 | 0.030 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 611 | 0.030 |
Why?
|
Pyridostigmine Bromide | 1 | 2014 | 31 | 0.030 |
Why?
|
Xylose | 1 | 1994 | 28 | 0.030 |
Why?
|
4-Aminobenzoic Acid | 1 | 1994 | 22 | 0.030 |
Why?
|
Sheep | 2 | 1999 | 1441 | 0.030 |
Why?
|
Cartilage | 2 | 1988 | 806 | 0.030 |
Why?
|
Hydroxycholecalciferols | 1 | 1994 | 44 | 0.030 |
Why?
|
Guideline Adherence | 1 | 2005 | 2283 | 0.030 |
Why?
|
United States | 4 | 2023 | 72448 | 0.030 |
Why?
|
Abdominal Muscles | 1 | 1995 | 170 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2019 | 1344 | 0.030 |
Why?
|
Self-Examination | 1 | 2013 | 71 | 0.030 |
Why?
|
Meningomyelocele | 1 | 1995 | 170 | 0.030 |
Why?
|
Lymphography | 1 | 1994 | 188 | 0.030 |
Why?
|
Vitamin A Deficiency | 1 | 1994 | 88 | 0.030 |
Why?
|
Solutions | 1 | 1994 | 419 | 0.030 |
Why?
|
Autoantibodies | 1 | 2022 | 2119 | 0.030 |
Why?
|
Accidents, Traffic | 1 | 1999 | 814 | 0.030 |
Why?
|
Pregnancy Complications, Neoplastic | 1 | 1996 | 255 | 0.030 |
Why?
|
Diseases in Twins | 1 | 1995 | 447 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2009 | 8512 | 0.030 |
Why?
|
Foreign Bodies | 1 | 1997 | 397 | 0.030 |
Why?
|
Health Status Indicators | 1 | 1999 | 968 | 0.030 |
Why?
|
Pancreatic Neoplasms | 2 | 2009 | 5349 | 0.030 |
Why?
|
Therapeutic Irrigation | 1 | 1994 | 292 | 0.030 |
Why?
|
Biofeedback, Psychology | 1 | 1994 | 116 | 0.030 |
Why?
|
Immunoglobulin G | 4 | 2008 | 4542 | 0.030 |
Why?
|
Lidocaine | 1 | 1996 | 538 | 0.030 |
Why?
|
Mutation | 3 | 2019 | 29957 | 0.030 |
Why?
|
Spinal Cord Neoplasms | 1 | 1995 | 264 | 0.030 |
Why?
|
Hospital Bed Capacity, 300 to 499 | 1 | 1992 | 57 | 0.030 |
Why?
|
Lung Abscess | 1 | 1992 | 41 | 0.030 |
Why?
|
Bacterial Outer Membrane Proteins | 1 | 1995 | 407 | 0.030 |
Why?
|
Intestinal Absorption | 1 | 1994 | 400 | 0.030 |
Why?
|
Duodenal Neoplasms | 1 | 1993 | 115 | 0.030 |
Why?
|
Feasibility Studies | 2 | 2014 | 5201 | 0.030 |
Why?
|
Alkylating Agents | 1 | 1993 | 133 | 0.030 |
Why?
|
Hamartoma | 1 | 1994 | 235 | 0.030 |
Why?
|
Thyroid Gland | 2 | 2013 | 1168 | 0.030 |
Why?
|
Immunoglobulins | 1 | 1995 | 859 | 0.030 |
Why?
|
Body Weight | 3 | 1996 | 4611 | 0.030 |
Why?
|
Bronchial Fistula | 1 | 1992 | 83 | 0.030 |
Why?
|
Gene Expression | 1 | 2005 | 7587 | 0.030 |
Why?
|
Intestinal Perforation | 1 | 2014 | 250 | 0.030 |
Why?
|
Second-Look Surgery | 1 | 2011 | 27 | 0.030 |
Why?
|
Neurologic Examination | 1 | 1995 | 916 | 0.020 |
Why?
|
Respiratory Tract Diseases | 1 | 1997 | 748 | 0.020 |
Why?
|
Paraganglioma | 1 | 1993 | 142 | 0.020 |
Why?
|
Pleural Diseases | 1 | 1992 | 137 | 0.020 |
Why?
|
Gastric Emptying | 1 | 1994 | 243 | 0.020 |
Why?
|
Intraoperative Care | 1 | 1995 | 768 | 0.020 |
Why?
|
Constriction, Pathologic | 1 | 1995 | 1098 | 0.020 |
Why?
|
Fetal Diseases | 2 | 1995 | 911 | 0.020 |
Why?
|
Psychological Tests | 1 | 2013 | 639 | 0.020 |
Why?
|
Papilloma | 1 | 1992 | 141 | 0.020 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2011 | 40 | 0.020 |
Why?
|
Biopsy, Fine-Needle | 1 | 2016 | 1110 | 0.020 |
Why?
|
Granulosa Cell Tumor | 1 | 1992 | 72 | 0.020 |
Why?
|
Odds Ratio | 2 | 2016 | 9716 | 0.020 |
Why?
|
Pneumococcal Infections | 1 | 1996 | 503 | 0.020 |
Why?
|
Thoracotomy | 1 | 1993 | 363 | 0.020 |
Why?
|
Piperidines | 1 | 2019 | 1650 | 0.020 |
Why?
|
Cryptorchidism | 1 | 1992 | 151 | 0.020 |
Why?
|
Rats, Inbred F344 | 2 | 1982 | 825 | 0.020 |
Why?
|
Predictive Value of Tests | 3 | 2014 | 15286 | 0.020 |
Why?
|
Polymerase Chain Reaction | 2 | 2010 | 6065 | 0.020 |
Why?
|
Goiter | 1 | 2011 | 87 | 0.020 |
Why?
|
Chromosomes, Human, Pair 20 | 1 | 1991 | 127 | 0.020 |
Why?
|
Pressure | 1 | 1994 | 1156 | 0.020 |
Why?
|
Diphtheria Toxoid | 1 | 1990 | 26 | 0.020 |
Why?
|
Fluorouracil | 2 | 2008 | 1631 | 0.020 |
Why?
|
Portoenterostomy, Hepatic | 1 | 1990 | 22 | 0.020 |
Why?
|
Mesalamine | 1 | 2011 | 136 | 0.020 |
Why?
|
Collagen | 3 | 1985 | 2636 | 0.020 |
Why?
|
Gadolinium DTPA | 1 | 1993 | 823 | 0.020 |
Why?
|
Evaluation Studies as Topic | 1 | 1992 | 1628 | 0.020 |
Why?
|
Genetic Markers | 1 | 1996 | 2609 | 0.020 |
Why?
|
Menstruation | 2 | 1981 | 307 | 0.020 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 1991 | 313 | 0.020 |
Why?
|
Neisseria meningitidis | 1 | 1990 | 107 | 0.020 |
Why?
|
Suture Techniques | 1 | 1995 | 790 | 0.020 |
Why?
|
Cystadenoma, Mucinous | 1 | 2009 | 62 | 0.020 |
Why?
|
Salvage Therapy | 1 | 1996 | 1268 | 0.020 |
Why?
|
Femoral Nerve | 1 | 1989 | 42 | 0.020 |
Why?
|
Hypocalcemia | 1 | 2011 | 199 | 0.020 |
Why?
|
Biliary Atresia | 1 | 1990 | 88 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2010 | 422 | 0.020 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12159 | 0.020 |
Why?
|
Nutritional Support | 1 | 2011 | 172 | 0.020 |
Why?
|
Drug Therapy, Combination | 3 | 2007 | 6498 | 0.020 |
Why?
|
Cranial Irradiation | 1 | 1992 | 391 | 0.020 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 1995 | 867 | 0.020 |
Why?
|
Mesna | 1 | 2008 | 62 | 0.020 |
Why?
|
Radiation Dosage | 1 | 2017 | 1957 | 0.020 |
Why?
|
Catheterization, Central Venous | 1 | 2014 | 526 | 0.020 |
Why?
|
WT1 Proteins | 1 | 2009 | 184 | 0.020 |
Why?
|
Hyperthyroidism | 1 | 2011 | 291 | 0.020 |
Why?
|
Immunoglobulin A | 1 | 1992 | 978 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2013 | 1180 | 0.020 |
Why?
|
Immunization, Passive | 1 | 1991 | 616 | 0.020 |
Why?
|
Medical Illustration | 1 | 1989 | 135 | 0.020 |
Why?
|
Anesthesia, Local | 1 | 1991 | 276 | 0.020 |
Why?
|
Osteochondroma | 1 | 2008 | 44 | 0.020 |
Why?
|
Sarcoma, Synovial | 1 | 2009 | 151 | 0.020 |
Why?
|
Platelet Count | 1 | 1991 | 777 | 0.020 |
Why?
|
Radionuclide Imaging | 1 | 1992 | 1975 | 0.020 |
Why?
|
Hand Deformities, Congenital | 1 | 1989 | 174 | 0.020 |
Why?
|
Leiomyoma | 1 | 1993 | 654 | 0.020 |
Why?
|
Endoscopy, Digestive System | 1 | 2011 | 351 | 0.020 |
Why?
|
Ampulla of Vater | 1 | 1989 | 149 | 0.020 |
Why?
|
Bone Cysts, Aneurysmal | 1 | 2008 | 70 | 0.020 |
Why?
|
Dilatation, Pathologic | 2 | 1995 | 527 | 0.020 |
Why?
|
Sweating | 1 | 2009 | 154 | 0.020 |
Why?
|
Flow Cytometry | 1 | 1998 | 5869 | 0.020 |
Why?
|
Spirometry | 1 | 2011 | 924 | 0.020 |
Why?
|
Urogenital Neoplasms | 1 | 1989 | 135 | 0.020 |
Why?
|
Physical Examination | 1 | 2013 | 1244 | 0.020 |
Why?
|
Brachytherapy | 1 | 1995 | 1238 | 0.020 |
Why?
|
Immunoglobulin M | 1 | 1992 | 1529 | 0.020 |
Why?
|
Fetus | 1 | 1995 | 1859 | 0.020 |
Why?
|
Drug Combinations | 1 | 1993 | 2025 | 0.020 |
Why?
|
Melphalan | 1 | 2008 | 421 | 0.020 |
Why?
|
Cholestasis | 1 | 1990 | 377 | 0.020 |
Why?
|
Hemoptysis | 1 | 1988 | 152 | 0.020 |
Why?
|
Bone Nails | 1 | 1988 | 218 | 0.020 |
Why?
|
Spinal Cord | 1 | 1995 | 1817 | 0.020 |
Why?
|
Quality Control | 1 | 2009 | 828 | 0.020 |
Why?
|
Bile Duct Neoplasms | 1 | 1992 | 601 | 0.020 |
Why?
|
Tachycardia | 1 | 2009 | 603 | 0.020 |
Why?
|
Workload | 1 | 1992 | 847 | 0.020 |
Why?
|
Prednisone | 1 | 1991 | 1566 | 0.020 |
Why?
|
Penicillium | 1 | 1985 | 22 | 0.020 |
Why?
|
Pericardial Effusion | 1 | 1988 | 247 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2017 | 3486 | 0.020 |
Why?
|
Chondrosarcoma | 1 | 2008 | 296 | 0.020 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2008 | 628 | 0.020 |
Why?
|
Abdomen | 1 | 2012 | 1130 | 0.020 |
Why?
|
Analysis of Variance | 3 | 2004 | 6238 | 0.020 |
Why?
|
Intraoperative Complications | 2 | 2001 | 1186 | 0.020 |
Why?
|
Antibodies, Monoclonal, Murine-Derived | 1 | 2008 | 693 | 0.020 |
Why?
|
Doxazosin | 1 | 2005 | 18 | 0.020 |
Why?
|
Carcinoma, Papillary | 1 | 2011 | 785 | 0.020 |
Why?
|
Liver | 4 | 1996 | 7510 | 0.020 |
Why?
|
Nitrogen | 2 | 1984 | 350 | 0.020 |
Why?
|
Pregnancy | 4 | 2002 | 29746 | 0.020 |
Why?
|
Fatal Outcome | 1 | 2010 | 1832 | 0.020 |
Why?
|
Antibody Formation | 1 | 1990 | 1400 | 0.020 |
Why?
|
Family Health | 1 | 2010 | 1257 | 0.020 |
Why?
|
Intestines | 1 | 2014 | 1907 | 0.020 |
Why?
|
Logistic Models | 2 | 2010 | 13312 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2010 | 1008 | 0.020 |
Why?
|
Pneumothorax | 1 | 1988 | 379 | 0.020 |
Why?
|
Diastole | 1 | 2007 | 788 | 0.020 |
Why?
|
Bacterial Capsules | 2 | 1996 | 242 | 0.010 |
Why?
|
Morbidity | 1 | 2010 | 1765 | 0.010 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2008 | 547 | 0.010 |
Why?
|
Middle Aged | 9 | 2006 | 220359 | 0.010 |
Why?
|
Antibodies, Viral | 1 | 1996 | 3142 | 0.010 |
Why?
|
Estradiol | 2 | 1981 | 1932 | 0.010 |
Why?
|
Vitamin D Deficiency | 1 | 1994 | 1379 | 0.010 |
Why?
|
Chromosome Aberrations | 1 | 1991 | 1767 | 0.010 |
Why?
|
Sensitivity and Specificity | 2 | 2010 | 14661 | 0.010 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 1984 | 64 | 0.010 |
Why?
|
Thromboembolism | 1 | 2011 | 1016 | 0.010 |
Why?
|
Cyclosporine | 1 | 2007 | 777 | 0.010 |
Why?
|
Program Evaluation | 1 | 1992 | 2493 | 0.010 |
Why?
|
Carcinoma, Renal Cell | 1 | 1999 | 3218 | 0.010 |
Why?
|
Exercise Tolerance | 1 | 2008 | 830 | 0.010 |
Why?
|
Heparin | 1 | 2011 | 1652 | 0.010 |
Why?
|
Anemia | 2 | 1985 | 1511 | 0.010 |
Why?
|
Peritoneal Neoplasms | 1 | 2010 | 707 | 0.010 |
Why?
|
Probability | 1 | 2008 | 2475 | 0.010 |
Why?
|
Neuroendocrine Tumors | 1 | 2009 | 650 | 0.010 |
Why?
|
Candidiasis | 1 | 1985 | 363 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 1993 | 1424 | 0.010 |
Why?
|
Myeloablative Agonists | 1 | 2003 | 209 | 0.010 |
Why?
|
Osteotomy | 1 | 1988 | 836 | 0.010 |
Why?
|
Malabsorption Syndromes | 1 | 1983 | 135 | 0.010 |
Why?
|
Scoliosis | 1 | 1989 | 735 | 0.010 |
Why?
|
Image Enhancement | 1 | 1993 | 2881 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2009 | 2698 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6476 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 2 | 2017 | 17790 | 0.010 |
Why?
|
Cisplatin | 1 | 2008 | 1643 | 0.010 |
Why?
|
Castration | 1 | 1982 | 153 | 0.010 |
Why?
|
Muscular Diseases | 1 | 1987 | 551 | 0.010 |
Why?
|
Massachusetts | 1 | 2015 | 8803 | 0.010 |
Why?
|
Pedigree | 1 | 2010 | 4578 | 0.010 |
Why?
|
Academic Medical Centers | 1 | 2012 | 2754 | 0.010 |
Why?
|
Thoracic Surgery | 1 | 1988 | 725 | 0.010 |
Why?
|
Abnormalities, Multiple | 1 | 1989 | 1415 | 0.010 |
Why?
|
Procollagen | 1 | 1982 | 188 | 0.010 |
Why?
|
Blood Pressure | 2 | 2010 | 8525 | 0.010 |
Why?
|
Phosphoric Monoester Hydrolases | 1 | 2004 | 413 | 0.010 |
Why?
|
Germ-Line Mutation | 1 | 2010 | 1842 | 0.010 |
Why?
|
Hernia, Umbilical | 1 | 2003 | 102 | 0.010 |
Why?
|
Oligospermia | 1 | 1981 | 59 | 0.010 |
Why?
|
Liver Diseases | 1 | 1990 | 1302 | 0.010 |
Why?
|
Polyvinyls | 1 | 1982 | 154 | 0.010 |
Why?
|
Graft Survival | 1 | 2012 | 3795 | 0.010 |
Why?
|
Sarcoma, Experimental | 1 | 1981 | 117 | 0.010 |
Why?
|
Thiotepa | 1 | 1981 | 66 | 0.010 |
Why?
|
Spine | 1 | 1988 | 1111 | 0.010 |
Why?
|
Fat Emulsions, Intravenous | 1 | 1984 | 314 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2006 | 58980 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2022 | 25941 | 0.010 |
Why?
|
Mechlorethamine | 1 | 1981 | 129 | 0.010 |
Why?
|
Drainage | 1 | 1987 | 1161 | 0.010 |
Why?
|
Skin Physiological Phenomena | 1 | 1981 | 188 | 0.010 |
Why?
|
Bone Marrow Transplantation | 1 | 2008 | 2693 | 0.010 |
Why?
|
Neutropenia | 1 | 1986 | 884 | 0.010 |
Why?
|
Sperm Count | 1 | 1981 | 228 | 0.010 |
Why?
|
Breast | 1 | 1989 | 1963 | 0.010 |
Why?
|
Radiography, Abdominal | 1 | 1983 | 532 | 0.010 |
Why?
|
Neurosurgical Procedures | 1 | 2011 | 2056 | 0.010 |
Why?
|
Aortic Aneurysm | 1 | 1985 | 646 | 0.010 |
Why?
|
Heart Failure | 1 | 2004 | 11848 | 0.010 |
Why?
|
Rats | 4 | 1990 | 23709 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16548 | 0.010 |
Why?
|
Blood Component Removal | 1 | 2000 | 132 | 0.010 |
Why?
|
Azathioprine | 1 | 1981 | 356 | 0.010 |
Why?
|
Animals | 8 | 1999 | 167960 | 0.010 |
Why?
|
Epidemiologic Methods | 1 | 2004 | 1343 | 0.010 |
Why?
|
Urologic Surgical Procedures, Male | 1 | 1999 | 80 | 0.010 |
Why?
|
Minnesota | 1 | 1999 | 340 | 0.010 |
Why?
|
Blood Proteins | 1 | 1984 | 1173 | 0.010 |
Why?
|
Rectal Diseases | 1 | 2000 | 144 | 0.010 |
Why?
|
Hospitals, University | 1 | 2001 | 568 | 0.010 |
Why?
|
Pneumonectomy | 1 | 1985 | 1111 | 0.010 |
Why?
|
Frozen Sections | 1 | 1999 | 153 | 0.010 |
Why?
|
Colonic Diseases | 1 | 2000 | 200 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 1996 | 3802 | 0.010 |
Why?
|
Body Temperature | 1 | 1981 | 777 | 0.010 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2009 | 1722 | 0.010 |
Why?
|
Parents | 1 | 1992 | 3549 | 0.010 |
Why?
|
Atrophy | 1 | 1983 | 1626 | 0.010 |
Why?
|
Algorithms | 1 | 1999 | 13982 | 0.010 |
Why?
|
Hospitals, Community | 1 | 2001 | 367 | 0.010 |
Why?
|
Fever | 1 | 1986 | 1617 | 0.010 |
Why?
|
Amino Acids | 1 | 1984 | 1714 | 0.010 |
Why?
|
Amenorrhea | 1 | 1981 | 480 | 0.010 |
Why?
|
Liver Transplantation | 1 | 1990 | 2325 | 0.010 |
Why?
|
Diploidy | 1 | 1998 | 132 | 0.010 |
Why?
|
PTEN Phosphohydrolase | 1 | 2004 | 1115 | 0.010 |
Why?
|
Gene Amplification | 2 | 1993 | 1085 | 0.010 |
Why?
|
Diarrhea | 1 | 1983 | 1319 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12531 | 0.010 |
Why?
|
Gastritis | 1 | 1998 | 198 | 0.010 |
Why?
|
Patient Satisfaction | 1 | 2008 | 3448 | 0.010 |
Why?
|
Pulmonary Alveoli | 1 | 1999 | 653 | 0.010 |
Why?
|
Prevalence | 1 | 2013 | 15686 | 0.010 |
Why?
|
Chronic Disease | 1 | 1991 | 9288 | 0.010 |
Why?
|
Surgical Procedures, Operative | 1 | 2007 | 1913 | 0.010 |
Why?
|
Karyotyping | 1 | 1998 | 1172 | 0.010 |
Why?
|
Palliative Care | 1 | 2011 | 3607 | 0.010 |
Why?
|
Ileal Diseases | 1 | 1995 | 69 | 0.010 |
Why?
|
Aged | 2 | 2006 | 169143 | 0.010 |
Why?
|
Serotyping | 1 | 1996 | 324 | 0.010 |
Why?
|
Meningococcal Vaccines | 1 | 1995 | 94 | 0.010 |
Why?
|
Pleural Effusion | 1 | 1998 | 343 | 0.010 |
Why?
|
Anticoagulants | 1 | 2011 | 4897 | 0.010 |
Why?
|
Internet | 1 | 2007 | 3078 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2005 | 4286 | 0.010 |
Why?
|
Echocardiography | 1 | 1987 | 4981 | 0.010 |
Why?
|
Cytotoxicity Tests, Immunologic | 1 | 1975 | 321 | 0.010 |
Why?
|
Germinoma | 1 | 1995 | 132 | 0.010 |
Why?
|
Ventricular Function, Left | 1 | 2007 | 3880 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2010 | 8055 | 0.010 |
Why?
|
Aneuploidy | 1 | 1998 | 551 | 0.010 |
Why?
|
Organ Size | 1 | 1999 | 2254 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2009 | 9406 | 0.010 |
Why?
|
Myenteric Plexus | 1 | 1993 | 44 | 0.010 |
Why?
|
Tumor Suppressor Proteins | 1 | 2004 | 2802 | 0.010 |
Why?
|
Antibodies, Neoplasm | 1 | 1975 | 280 | 0.010 |
Why?
|
Ganglia, Autonomic | 1 | 1993 | 43 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2009 | 14494 | 0.010 |
Why?
|
Ectoderm | 1 | 1993 | 137 | 0.010 |
Why?
|
Chromosome Deletion | 1 | 1998 | 1387 | 0.010 |
Why?
|
Inflammation | 1 | 1992 | 10755 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2011 | 7408 | 0.010 |
Why?
|
Internship and Residency | 1 | 1992 | 5870 | 0.010 |
Why?
|
Pneumococcal Vaccines | 1 | 1996 | 397 | 0.010 |
Why?
|
Antibodies, Monoclonal | 1 | 2008 | 9185 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2009 | 11902 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 1995 | 1032 | 0.010 |
Why?
|
Immunization | 1 | 1996 | 1227 | 0.010 |
Why?
|
Hernia, Ventral | 1 | 1995 | 214 | 0.010 |
Why?
|
Gallbladder | 1 | 1992 | 305 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 1999 | 4815 | 0.010 |
Why?
|
Intestinal Diseases | 1 | 1995 | 506 | 0.010 |
Why?
|
Deficiency Diseases | 1 | 1990 | 74 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1993 | 2558 | 0.010 |
Why?
|
Macrophages | 1 | 1985 | 5745 | 0.010 |
Why?
|
Trisomy | 1 | 1991 | 260 | 0.010 |
Why?
|
Wounds and Injuries | 1 | 1982 | 2477 | 0.010 |
Why?
|
Rats, Inbred Strains | 1 | 1990 | 2094 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1981 | 10826 | 0.000 |
Why?
|
Pilot Projects | 1 | 2001 | 8556 | 0.000 |
Why?
|
Comorbidity | 1 | 2002 | 10553 | 0.000 |
Why?
|
Tars | 1 | 1967 | 20 | 0.000 |
Why?
|
Marfan Syndrome | 1 | 1989 | 236 | 0.000 |
Why?
|
Plants, Toxic | 1 | 1967 | 74 | 0.000 |
Why?
|
Pancreatic Ducts | 1 | 1989 | 329 | 0.000 |
Why?
|
Lymphocytes | 1 | 1975 | 2611 | 0.000 |
Why?
|
Graft Rejection | 1 | 1999 | 4426 | 0.000 |
Why?
|
Ilium | 1 | 1987 | 154 | 0.000 |
Why?
|
Proteins | 1 | 1981 | 6029 | 0.000 |
Why?
|
Tissue and Organ Procurement | 1 | 1994 | 944 | 0.000 |
Why?
|
Cell Differentiation | 1 | 2003 | 11481 | 0.000 |
Why?
|
Ultrasonics | 1 | 1987 | 207 | 0.000 |
Why?
|
Gastrointestinal Neoplasms | 1 | 1993 | 951 | 0.000 |
Why?
|
Tissue Donors | 1 | 1994 | 2314 | 0.000 |
Why?
|
Cardiac Surgical Procedures | 1 | 1999 | 3620 | 0.000 |
Why?
|
Pregnancy Outcome | 1 | 1995 | 2907 | 0.000 |
Why?
|
Genital Neoplasms, Female | 1 | 1989 | 533 | 0.000 |
Why?
|
Nicotine | 1 | 1967 | 677 | 0.000 |
Why?
|
Methylhistidines | 1 | 1981 | 35 | 0.000 |
Why?
|
Glioblastoma | 1 | 1975 | 3482 | 0.000 |
Why?
|
Wounds, Gunshot | 1 | 1985 | 581 | 0.000 |
Why?
|
Models, Biological | 1 | 1993 | 9468 | 0.000 |
Why?
|
Urinary Bladder Neoplasms | 1 | 1989 | 2275 | 0.000 |
Why?
|
Brain Neoplasms | 1 | 1995 | 8985 | 0.000 |
Why?
|
Protein Biosynthesis | 1 | 1981 | 2104 | 0.000 |
Why?
|
Neoplasms, Experimental | 1 | 1975 | 1229 | 0.000 |
Why?
|
Chemistry | 1 | 1967 | 348 | 0.000 |
Why?
|
Chemical Phenomena | 1 | 1967 | 508 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 1989 | 11345 | 0.000 |
Why?
|
Cell Line | 1 | 1975 | 15620 | 0.000 |
Why?
|
Smoking | 1 | 1967 | 9073 | 0.000 |
Why?
|